What are COVID-19 antibodies, is there a certain level needed for protection, and how well do COVID-19 vaccines work in people with cancer? In this Q&A, NCI experts discuss emerging research findings from the SeroNet program that are shedding light on these and other important questions.
The Importance of Building Trust in COVID-19 Vaccines
Multimedia National Institutes of Health (NIH)
Recent Advancement of Nanostructured Materials for Clinical Challenges in Vaccinology
How the National Cancer Act of 1971 Revolutionized Cancer Care and What Lies Ahead - The ASCO Post
Antibodies and Vaccines as Drugs for COVID-19, keystone symposia
Frontiers Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines
Case Western Reserve University researchers study how the immune system responds to COVID-19 The Daily The Daily
neutralizing antibodies – NIH Director's Blog
mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants
COVID-19 and Cancer: a Comprehensive Review
